Publications
5802 Results
- Journal / Conference
- Contemporary Clinical Trials Apr 8;22:100768. doi: 10.1016/j.conctc.2021.100768. eCollection 2021 Jun.
- Year
- 2021
- Research Committee(s)
- Palliative Care
- PMID
- PMID33997460
- PMC
- PMC8105629
- Study Number(s)
- S1820
SWOG S1820: Altering Intake, Managing Symptoms for Bowel Dysfunction in Survivors of Rectal Cancer (The AIMS-RC Intervention Trial)
- Journal / Conference
- Journal of the American Medical Association Apr 6;325(13):1277-1286. doi: 10.1001/jama.2021.2454.
- Year
- 2021
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID33821899
- PMC
- PMC8025124
- Study Number(s)
- CTSU/C80702
Effect of Celecoxib vs Placebo Added to Standard Adjuvant Therapy on Disease-Free Survival Among Patients With Stage III Colon Cancer: The CALGB/SWOG 80702 (Alliance) Randomized Clinical Trial
- Journal / Conference
- Journal of Clinical Oncology Aug 1;39(22):2486-2496; May 14;JCO2100286. doi: 10.1200/JCO.21.00286. Online ahead of print
- Year
- 2021
- Research Committee(s)
- Genitourinary
- PMID
- PMID33989025
- Study Number(s)
- CTSU/C90601
Randomized Phase III Trial of Gemcitabine and Cisplatin With Bevacizumab or Placebo in Patients With Advanced Urothelial Carcinoma: Results of CALGB 90601 (Alliance)
- Journal / Conference
- Annals of Oncology, Oct;32(10):1267-1275
- Year
- 2021
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID34293461
- PMC
- PMC8719434
- Study Number(s)
- CTSU/C80702
Combining tumor deposits with the number of lymph node metastases to improve the prognostic accuracy in stage III colon cancer: a post hoc analysis of the CALGB/SWOG 80702 phase III study (Alliance)
- Journal / Conference
- JCO Oncology Practice Jul;17(7):e908-e916; Apr 26;OP2000990. doi: 10.1200/OP.20.00990. Online ahead of print
- Year
- 2021
- PMID
- PMID33900801
- PMC
- PMC8462669
Hope, Burnout, and Life Satisfaction: An Intriguing Trinity Among Investigators of the SWOG Cancer Research Network
- Journal / Conference
- J Clin Oncol 39, 2021 (suppl 6; abstr 428) (ASCO GU Cancers Symposium (Feb 13-15, 2021 virtual), poster)
- Year
- 2021
- Research Committee(s)
- Genitourinary
- Study Number(s)
- S1806
INTACT (S/N1806): Phase III Randomized Trial of Concurrent Chemoradiotherapy with or without Atezolizumab in Localized Muscle Invasive Bladder Cancer. Toxicity update on first 73 patients
- Journal / Conference
- J Clin Oncol 39, 2021 (suppl 15; abstr 4541) (American Society of Clinical Oncology Annual Meeting 2021, poster session)
- Year
- 2021
- Research Committee(s)
- Genitourinary
- Study Number(s)
- S1605
Phase II Trial of Atezolizumab in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer: SWOG S1605 (NCT #02844816)
- Journal / Conference
- J Clin Oncol 39, 2021 (suppl 15; abstr 4131) (American Society of Clinical Oncology Annual Meeting 2021, poster session)
- Year
- 2021
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- S1505
Body Composition Measurements and Overall Survival in Patients with Resectable Pancreatic Adenocarcinoma (SWOG Study S1505)
- Journal / Conference
- J Clin Oncol 39, 2021 (suppl 15; abstr 4104) (American Society of Clinical Oncology Annual Meeting 2021, poster session)
- Year
- 2021
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- S0809
Does Adjuvant Chemoradiation Benefit Patients with Lymph Node Positive Biliary Tract Cancers? : A Secondary Analysis of SWOG S0809
- Journal / Conference
- J Clin Oncol 39, 2021 (suppl 15; abstr 9075) (American Society of Clinical Oncology Annual Meeting 2021, poster session)
- Year
- 2021
- Research Committee(s)
- Lung
- Study Number(s)
- S1800A